Home » Topics » Regulatory

Regulatory
RSS

Celecoxib: use in inflammatory conditions of the head and neck

April 18, 2000

Sanofi-Synthelabo begins rolling out Xatral XL in Europe

April 18, 2000

Enbrel recommended by FDA advisory committee for early RA

April 17, 2000

SangCya approved in Germany

April 12, 2000

Apligraf PMA supplement tentatively scheduled for FDA review in May

April 11, 2000

New formulation of Hectorol approved by FDA

April 11, 2000

Bayer obtains first approval worldwide for new antiallergic agent

April 11, 2000

FDA gives go-ahead for Access to commence OraDisc clinical trials

April 5, 2000

Another indication for Enbrel will be discussed at advisory committee meeting

April 5, 2000

CollaGenex seeks FDA approval for new dosage form of Periostat

April 5, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.